CBU
GSK icon

CIBC Bank USA’s GSK GSK Stock Holding History

CIBC Bank USA’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,979
Closed -$221K – 270
2017
Q4 		$221K Buy
+4,979
New +$230K 0.03% 240
2017
Q3 		– Sell
-4,989
Closed -$268K – 278
2017
Q2 		$268K Sell
4,989
-4,121
-45% -$220K 0.04% 216
2017
Q1 		$480K Sell
9,110
-344
-4% -$17.5K 0.07% 156
2016
Q4 		$456K Sell
9,454
-564
-6% -$27.9K 0.07% 156
2016
Q3 		$540K Sell
10,018
-942
-9% -$51.6K 0.08% 144
2016
Q2 		$594K Sell
10,960
-512
-4% -$27K 0.09% 133
2016
Q1 		$582K Buy
11,472
+918
+9% +$45.7K 0.1% 123
2015
Q4 		$532K Buy
10,554
+335
+3% +$17.1K 0.09% 139
2015
Q3 		$491K Buy
10,219
+625
+7% +$32.5K 0.09% 143
2015
Q2 		$499K Sell
9,594
-130
-1% -$7.32K 0.08% 154
2015
Q1 		$561K Sell
9,724
-538
-5% -$30.8K 0.1% 141
2014
Q4 		$549K Buy
10,262
+3,522
+52% +$197K 0.1% 159
2014
Q3 		$387K Sell
6,740
-3,704
-35% -$227K 0.08% 201
2014
Q2 		$698K Sell
10,444
-1,540
-13% -$104K 0.13% 130
2014
Q1 		$800K Buy
11,984
+3,688
+44% +$249K 0.17% 111
2013
Q4 		$554K Sell
8,296
-427
-5% -$27.7K 0.12% 172
2013
Q3 		$547K Sell
8,723
-29,613
-77% -$1.91M 0.13% 167
2013
Q2 		$2.39M Buy
+38,336
New +$2.43M 0.14% 116

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIBC Bank USA's GSK Position: Q1 2018 in Review

CIBC Bank USA sold out of GSK (GSK) in Q1 2018, closing a stake of 4,979 shares — an estimated $221K sold.

CIBC Bank USA first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $2.39M in Q2 2013. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • CIBC Bank USA reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • CIBC Bank USA sold 4,979 GSK shares in Q1 2018, an estimated $221K.
  • CIBC Bank USA first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • CIBC Bank USA's GSK position peaked at $2.39M in Q2 2013.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on CIBC Bank USA's 13F filing for Q1 2018, filed 11 Apr 2018.